Top global generic pharmaceutical companies by value as of 2016

As of 2016, among the top ten generic drugs manufacturing companies worldwide, Pfizer Established Pharma was the leading one based on company value. According to the given source, Pfizer Established Pharma (today: Essential Health) was valued at 84.6 billion U.S. dollars at that time. Hengrui was valued at some 13.2 billion U.S. dollars and was at the bottom of the top 10 generics companies during that year.

Generic pharmaceutical companies

In general, the U.S. generic pharmaceutical industry has seen significant growth in recent years. Certain players have shown to hold a bigger presence in the industry. Among the top 10 pharmaceutical companies by U.S. unbranded generics revenue in 2016-2017, Fresenius Kabi generated the least revenue and Teva generated the most revenue. Among all pharmaceutical companies (including non-generic), Pfizer was projected to be the top revenue generating company in the coming years based on prescription drug revenues worldwide.

Generic prescription drugs in the U.S.

The proportion of generic prescription drugs dispensed in the United States has increased dramatically over the last years. Increased generic usage has caused significant cost savings to the U.S. health system. Among all generic drugs available in the United States, the availability of atorvastatin (the generic form of Lipitor) has generated the most health cost savings in 2017.

Top 10 generic pharmaceutical companies worldwide by value as of 2016

Value in billion U.S. dollars
Pfizer Established Pharma84.62
Teva Generics (including Allergan Gx)70.3
Sandoz/Novartis36.49
Sun Pharma30.04
CR Pharmaceutical29.05
Yangtze River Pharma28.19
Mylan 28.17
EMS 16.46
Abbott Established Pharma14.58
Hengrui13.24
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2016

Region

Worldwide

Survey time period

as of February 16, 2016

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.